France’s National Authority for Health (HAS) has approved reimbursement for a digital therapy, a first for the country. The therapy, named Joe, is designed to help children with asthma better manage their treatment regimens. This positive assessment from the HAS marks a significant step towards integrating digital health solutions into the French healthcare system. Joe utilizes technology to support young asthma sufferers in adhering to prescribed medications. The approval signals growing acceptance of digital therapeutics as a viable healthcare intervention. This decision could pave the way for wider adoption of similar technologies aimed at improving patient care and outcomes. The HAS’s endorsement highlights the potential of digital tools to address chronic conditions in pediatric populations.